US OptionsDetailed Quotes
RGLS241220C1000
- 0.78
- 0.000.00%
15min DelayClose Nov 27 16:00 ET
0.00High0.00Low
0.78Open0.78Pre Close0 Volume1 Open Interest1.00Strike Price0.00Turnover297.61%IV8.54%PremiumDec 20, 2024Expiry Date0.64Intrinsic Value100Multiplier23DDays to Expiry0.14Extrinsic Value100Contract SizeAmericanOptions Type0.8511Delta0.1906Gamma2.10Leverage Ratio-0.0063Theta0.0004Rho1.79Eff Leverage0.0009Vega
Regulus Therapeutics Stock Discussion
Sign in to post a comment
$Visionary Holdings (GV.US)$ $Western Digital (WDC.US)$ $Integrated Media Technology (IMTE.US)$ $Deckers Outdoor (DECK.US)$ $MediaCo (MDIA.US)$ $Skechers USA (SKX.US)$ $Regulus Therapeutics (RGLS.US)$ $Abits (ABTS.US)$ $Spark I Acquisition Corporation (SPKL.US)$ $Tapestry (TPR.US)$ $Antelope Enterprise (AEHL.US)$ $Jeffs' Brands (JFBR.US)$ $Lyell Immunopharma (LYEL.US)$ $Smart Powerr (CREG.US)$ $Bionomics (BNOX.US)$
📊⚡️📊
📊⚡️📊
6
4
$Regulus Therapeutics (RGLS.US)$ Regulus Therapeutics Inc: Remain on Track for an End of Phase 1 Meeting With FDA by End of 2024
$Regulus Therapeutics (RGLS.US)$
Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
$Regulus Therapeutics (RGLS.US)$ is ready Almost there.🙌
$Regulus Therapeutics (RGLS.US)$
Vanguard loaded
Vanguard loaded
So ive been asked by quite a few people that are newer traders! And because of being where we all have been. They are learning charts and where to enter and exit on momentum / day trades. But having a bit of trouble. Again as we all did and at times still do. Most know that because i cant know others risk tolerance. Or the type of trade they are doing? That i do not give buy / sell advice. But i was asked could i give some swing trade ideas, so they could have a chance to ...
49
28
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
but you have these many holdings?
$Regulus Therapeutics (RGLS.US)$ probably going to below 1$
2
Positive Topline Data from Regulus Therapeutics' Phase 1b MAD Clinical Trial of RGLS8429 for ADPKD.
Regulus Therapeutics Inc., a biopharmaceutical company listed on Nasdaq under the ticker symbol RGLS, has recently announced positive topline results from the third cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) clinical trial of RGLS8429. This investigational drug is being developed for the treatment of ...
Regulus Therapeutics Inc., a biopharmaceutical company listed on Nasdaq under the ticker symbol RGLS, has recently announced positive topline results from the third cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) clinical trial of RGLS8429. This investigational drug is being developed for the treatment of ...
$Regulus Therapeutics (RGLS.US)$ Recovering. Gonna be a post market high or next day pre market runner. ?
1
$Regulus Therapeutics (RGLS.US)$ this chart looks like a pump and dump!?
No comment yet
Trademark-17 : why some your marking in red ?
Stock_Drift OP Trademark-17 : I’m not marking them, it’s a live ticker. It’s moving to the price fluctuations.
F HALE : where do i find this ticker
Trademark-17 : what your think for CREG for tomorrow?